Gana Ali Ahmad Tahmaz
Research Subjects
Gana Ali Ahmad Tahmaz has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Arij A A A A Alasfour1 shared publication
- Asal Ahmed Mohammed Al Azzawi1 shared publication
Asia Abdalla Shaheen Mohamed Abdalla
1 shared publicationHind Saleh Alhammadi
1 shared publication- Iqra Tahir1 shared publication
- Judy Al Hussami1 shared publication
Latest Publications
- Open Access
- 3 January 2025
- Published by Green Publication
- Vol. 32 (1) , 16-37
ROLE OF VITAMIN D SUPPLEMENTATION IN THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES
CVDs continue to create a burden in the global disease burden, hence the need to come up with better approaches to tackling the problem. Vitamin D has been related to cardiovascular health in addition to its well-known actions within the skeletal system through its inflammatory effects, effects on endothelial function, and ability to alter the renin-angiotensin-aldosterone system. Nevertheless, these pathways explain the theoretical mechanisms of how vitamin D supplementation prevents and treats CVD, but clinical effectiveness has not been precisely established. To assess the impact of vitamin D in preventing cardiovascular illness and its outcomes, original research before the year 2024, using randomized controlled trials, cohorts, and meta-analysis, was included in this systematic review. As previously mentioned, a PubMed, Scopus, and Web of Science search was performed and screened by quality and relevance. The present study presents an optimistic conclusion in some studies as there is a marked reduction in other risk factors, including blood pressure, lipid profiles, and arterial stiffness. However, other studies support a reduction or lack of benefit in some risk factors. These discrepancies seem to be influenced by differences in study type and duration, participants’ initial vitamin D levels, dose of supplement, and participants. Therefore, whether vitamin D supplementation should be issued universally for CVD prevention and management is still indistinct. This review provides a foundation on which targeted interventions may be designed and developed and demonstrates that more research is needed into the doses that might be effective and the patients most likely to benefit from them. Knowledge of the specifics of how vitamin D works in cardiovascular disease could be helpful in clinical guidelines and could help progress ways to limit global CVD.
- 3 January 2025
- Published by Green Publication
- Vol. 32 (1) , 16-37
Open AccessROLE OF VITAMIN D SUPPLEMENTATION IN THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES
CVDs continue to create a burden in the global disease burden, hence the need to come up with better approaches to tackling the problem. Vitamin D has been related to cardiovascular health in addition to its well-known actions within the skeletal system through its inflammatory effects, effects on endothelial function, and ability to alter the renin-angiotensin-aldosterone system. Nevertheless, these pathways explain the theoretical mechanisms of how vitamin D supplementation prevents and treats CVD, but clinical effectiveness has not been precisely established. To assess the impact of vitamin D in preventing cardiovascular illness and its outcomes, original research before the year 2024, using randomized controlled trials, cohorts, and meta-analysis, was included in this systematic review. As previously mentioned, a PubMed, Scopus, and Web of Science search was performed and screened by quality and relevance. The present study presents an optimistic conclusion in some studies as there is a marked reduction in other risk factors, including blood pressure, lipid profiles, and arterial stiffness. However, other studies support a reduction or lack of benefit in some risk factors. These discrepancies seem to be influenced by differences in study type and duration, participants’ initial vitamin D levels, dose of supplement, and participants. Therefore, whether vitamin D supplementation should be issued universally for CVD prevention and management is still indistinct. This review provides a foundation on which targeted interventions may be designed and developed and demonstrates that more research is needed into the doses that might be effective and the patients most likely to benefit from them. Knowledge of the specifics of how vitamin D works in cardiovascular disease could be helpful in clinical guidelines and could help progress ways to limit global CVD.